https://www.selleckchem.com/pr....oducts/cordycepin.ht
OI-based model showed better performance and could instruct surgical approach in the future. 3 TECHNICAL EFFICACY Stage 4. 3 TECHNICAL EFFICACY Stage 4. Neuroinflammation and probably systemic inflammation, with abnormal α-synuclein deposition, participate in the development of Parkinson's disease (PD). The P2X7 receptor/NLRP3 inflammasome complex is upregulated in the brain of PD patients. By a prospective approach, the degree of systemic activation of such complex, and its regulatory mechanisms, were explored in treatment-naïve PD
Like
Comment
Share
